Long-Term Assets: The sum of all assets classified as non-current.
Climb Bio, Inc. (CLYM) had Long-Term Assets of $59.66M for the most recently reported fiscal quarter, ending 2026-06-30.
| Income Statement Financials | |
-- |
|
$-13.50M |
|
-- |
|
-- |
|
$15.36M |
|
$-15.36M |
|
$1.86M |
|
$-13.50M |
|
$-13.50M |
|
$-13.50M |
|
$-13.50M |
|
$-13.50M |
|
$-13.50M |
|
$-15.36M |
|
$-15.71M |
|
76.15M |
|
76.15M |
|
$-0.18 |
|
$-0.18 |
|
| Balance Sheet Financials | |
$186.64M |
|
$0.69M |
|
|
Long-Term Assets |
$59.66M |
$246.29M |
|
$5.93M |
|
-- |
|
$0.81M |
|
$6.75M |
|
$239.55M |
|
$239.55M |
|
$239.55M |
|
57.44M |
|
| Cash Flow Statement Financials | |
$-24.93M |
|
$-70.22M |
|
$103.71M |
|
$35.69M |
|
$44.25M |
|
$8.56M |
|
$3.09M |
|
-- |
|
-- |
|
| Fundamental Metrics & Ratios | |
31.45 |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
$-25.18M |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-5.63% |
|
-5.63% |
|
-5.48% |
|
-5.63% |
|
$4.17 |
|
$-0.33 |
|
$-0.33 |
|